122 related articles for article (PubMed ID: 1611305)
1. Matrix vesicles contain metalloproteinases that degrade proteoglycans.
Dean DD; Schwartz ZV; Muniz OE; Gomez R; Swain LD; Howell DS; Boyan BD
Bone Miner; 1992 May; 17(2):172-6. PubMed ID: 1611305
[TBL] [Abstract][Full Text] [Related]
2. Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans.
Dean DD; Schwartz Z; Muniz OE; Gomez R; Swain LD; Howell DS; Boyan BD
Calcif Tissue Int; 1992 Apr; 50(4):342-9. PubMed ID: 1571846
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner.
Dean DD; Boyan BD; Muniz OE; Howell DS; Schwartz Z
Calcif Tissue Int; 1996 Aug; 59(2):109-16. PubMed ID: 8687979
[TBL] [Abstract][Full Text] [Related]
4. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
[TBL] [Abstract][Full Text] [Related]
5. Matrix vesicles produced by osteoblast-like cells in culture become significantly enriched in proteoglycan-degrading metalloproteinases after addition of beta-glycerophosphate and ascorbic acid.
Dean DD; Schwartz Z; Bonewald L; Muniz OE; Morales S; Gomez R; Brooks BP; Qiao M; Howell DS; Boyan BD
Calcif Tissue Int; 1994 May; 54(5):399-408. PubMed ID: 8062158
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D regulation of metalloproteinase activity in matrix vesicles.
Dean DD; Schwartz Z; Schmitz J; Muniz OE; Lu Y; Calderon F; Howell DS; Boyan BD
Connect Tissue Res; 1996; 35(1-4):331-6. PubMed ID: 9084672
[TBL] [Abstract][Full Text] [Related]
7. Metalloproteinase activity in growth plate chondrocyte cultures is regulated by 1,25-(OH)(2)D(3) and 24,25-(OH)(2)D(3) and mediated through protein kinase C.
Maeda S; Dean DD; Sylvia VL; Boyan BD; Schwartz Z
Matrix Biol; 2001 Apr; 20(2):87-97. PubMed ID: 11334710
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro.
Boyan BD; Schwartz Z; Swain LD; Carnes DL; Zislis T
Bone; 1988; 9(3):185-94. PubMed ID: 3166834
[TBL] [Abstract][Full Text] [Related]
9. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles.
Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD
J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C.
Schmitz JP; Schwartz Z; Sylvia VL; Dean DD; Calderon F; Boyan BD
J Cell Physiol; 1996 Sep; 168(3):570-9. PubMed ID: 8816911
[TBL] [Abstract][Full Text] [Related]
11. Role of metalloproteinases in human osteoarthritis.
Woessner JF; Gunja-Smith Z
J Rheumatol Suppl; 1991 Feb; 27():99-101. PubMed ID: 1851233
[TBL] [Abstract][Full Text] [Related]
12. Matrix vesicles as a marker of endochondral ossification.
Boyan BD; Schwartz Z; Swain LD
Connect Tissue Res; 1990; 24(1):67-75. PubMed ID: 2338026
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate.
Brown CC; Hembry RM; Reynolds JJ
J Bone Joint Surg Am; 1989 Apr; 71(4):580-93. PubMed ID: 2539384
[TBL] [Abstract][Full Text] [Related]
14. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
15. Regulation of matrix vesicle phospholipid metabolism is cell maturation-dependent.
Swain LD; Schwartz Z; Boyan BD
Bone Miner; 1992 May; 17(2):192-6. PubMed ID: 1319251
[TBL] [Abstract][Full Text] [Related]
16. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities.
Schwartz Z; Schlader DL; Swain LD; Boyan BD
Endocrinology; 1988 Dec; 123(6):2878-84. PubMed ID: 3264240
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts.
Overall CM; Wrana JL; Sodek J
Connect Tissue Res; 1989; 20(1-4):289-94. PubMed ID: 2558843
[TBL] [Abstract][Full Text] [Related]
18. Regulation of arachidonic acid turnover by 1,25-(OH)2D3 and 24,25-(OH)2D3 in growth zone and resting zone chondrocyte cultures.
Schwartz Z; Swain LD; Ramirez V; Boyan BD
Biochim Biophys Acta; 1990 Sep; 1027(3):278-86. PubMed ID: 2397237
[TBL] [Abstract][Full Text] [Related]
19. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro.
Boyan BD; Schwartz Z; Carnes DL; Ramirez V
Endocrinology; 1988 Jun; 122(6):2851-60. PubMed ID: 2836176
[TBL] [Abstract][Full Text] [Related]
20. Specific MicroRNAs Found in Extracellular Matrix Vesicles Regulate Proliferation and Differentiation in Growth Plate Chondrocytes.
Asmussen NC; Cohen DJ; Lin Z; McClure MJ; Boyan BD; Schwartz Z
Calcif Tissue Int; 2021 Oct; 109(4):455-468. PubMed ID: 33950267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]